Title: Erratum: Omalizumab for treatment of ABPA exacerbations in CF patients
Abstract: Pediatric PulmonologyVolume 44, Issue 9 p. 943-944 ErratumFree Access Erratum: Omalizumab for treatment of ABPA exacerbations in CF patients Patrick Lebecque MD, PhD, Corresponding Author Patrick Lebecque MD, PhD [email protected] Pediatric Pulmonology & Cystic Fibrosis Unit, Cliniques St Luc, Université de Louvain, Brussels, Belgium10 avenue Hippocrate, Brussels 1200, Belgium.Search for more papers by this authorAnissa Leonard MD, Anissa Leonard MD Pediatric Pulmonology & Cystic Fibrosis Unit, Cliniques St Luc, Université de Louvain, Brussels, BelgiumSearch for more papers by this authorCharles Pilette MD, PhD, Charles Pilette MD, PhD Respiratory Medicine, Cliniques St Luc, Université de Louvain, Brussels, BelgiumSearch for more papers by this author Patrick Lebecque MD, PhD, Corresponding Author Patrick Lebecque MD, PhD [email protected] Pediatric Pulmonology & Cystic Fibrosis Unit, Cliniques St Luc, Université de Louvain, Brussels, Belgium10 avenue Hippocrate, Brussels 1200, Belgium.Search for more papers by this authorAnissa Leonard MD, Anissa Leonard MD Pediatric Pulmonology & Cystic Fibrosis Unit, Cliniques St Luc, Université de Louvain, Brussels, BelgiumSearch for more papers by this authorCharles Pilette MD, PhD, Charles Pilette MD, PhD Respiratory Medicine, Cliniques St Luc, Université de Louvain, Brussels, BelgiumSearch for more papers by this author First published: 13 August 2009 https://doi.org/10.1002/ppul.21129Citations: 3AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (Omalizumab). Pediatr Pulmonol 2008; 43: 1249–1251. 2 van der Ent KC, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007; 62: 276–277. 3 Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol 2008; 43: 607–610. 4 Lebecque P, Leonard A, Argaz M, Godding V, Pilette C. Omalizumab for exacerbations of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. BMJ Case Rep in press. Citing Literature Volume44, Issue9September 2009Pages 943-944 ReferencesRelatedInformation